ロード中...
Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response
Targeted delivery of a nanovaccine loaded with a tumor antigen and adjuvant to the lymph nodes (LNs) is an attractive approach for improving cancer immunotherapy outcomes. However, the application of this technique is restricted by the paucity of suitable tumor-associated antigens (TAAs) and the sop...
保存先:
| 出版年: | Nat Commun |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7048802/ https://ncbi.nlm.nih.gov/pubmed/32111828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-020-14906-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|